Hangjun Zhan
About
Hangjun Zhan is from San Mateo California United States of America. Hangjun is currently Chief Technology Officer at Attovia Therapeutics. In Hangjun's previous role as a CSO at Alamar Biosciences, Inc., Hangjun worked in until Jun 2023. Prior to joining Alamar Biosciences, Inc., Hangjun was a CSO at KindredBio_ELANCO (Nasdaq: ELAN) and held the position of CSO. Prior to that, Hangjun was a CSO and Officer at KindredBio (Nasdaq: KIN) from Jan 2018 to Jun 2021. Hangjun started working as SVP: VP and Head of Biologics Research at KindredBio (Nasdaq: KIN) in Feb 2014. From Jul 2010 to Feb 2014, Hangjun was Director (Executive) at Aragen Bioscience. Prior to that, Hangjun was a Sr. Director at Exelixis Inc (Nasdaq: EXEL), based in SSF from Mar 2000 to May 2010. Hangjun started working as Group Leader at Celera Genomics (Nasdaq: CRA; AXYS: ARRS) in Oct 1994.
If you’re looking for Hangjun Zhan's email address, you can find it on finalscout.com. Finalscout is a professional database with more than 500 million business professionals and 200 million company profiles.